BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica 2019;104:2107-15. [PMID: 30792199 DOI: 10.3324/haematol.2019.216796] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Lozano Jaramillo DA, Jimenez Ochoa MA. Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient. J Med Cases 2021;12:339-42. [PMID: 34527101 DOI: 10.14740/jmc3737] [Reference Citation Analysis]
2 Zheng L, Abdelgawwad MS, Zhang D, Xu L, Wei S, Cao W, Zheng XL. Histone-induced thrombotic thrombocytopenic purpura in adamts13 -/- zebrafish depends on von Willebrand factor. Haematologica 2020;105:1107-19. [PMID: 31753928 DOI: 10.3324/haematol.2019.237396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Laghmouchi A, Graça NAG, Voorberg J. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura. Front Immunol 2021;12:757192. [PMID: 34858410 DOI: 10.3389/fimmu.2021.757192] [Reference Citation Analysis]
4 Alharbi I, Alqarni S, Khayyat W, Almatrafi A. De Novo Mutation of the ADAMTS13 Gene with Mesenteric Ischemia in an Infant with Congenital Thrombotic Thrombocytopenic Purpura. Case Rep Hematol 2021;2021:5516863. [PMID: 34306773 DOI: 10.1155/2021/5516863] [Reference Citation Analysis]
5 Subhan M, Scully M. Advances in the management of TTP. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Coppo P, Lämmle B. Animal models of thrombotic thrombocytopenic purpura: the tales from zebrafish. Haematologica 2020;105:861-3. [PMID: 32238467 DOI: 10.3324/haematol.2019.245043] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2496-502. [PMID: 32914526 DOI: 10.1111/jth.15010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
8 Galstyan GM, Klebanova EE. [Diagnosis of thrombotic thrombocytopenic purpura]. Ter Arkh 2020;92:207-17. [PMID: 33720596 DOI: 10.26442/00403660.2020.12.200508] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wendt R, Kalbitz S, Otto F, Falter T, Beige J, Rossmann H, Lämmle B. Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker. Front Med (Lausanne) 2021;8:639441. [PMID: 33732721 DOI: 10.3389/fmed.2021.639441] [Reference Citation Analysis]
10 Enjeti AK, de Malmanche T, Chapman K, Ziolkowski A. Genomic investigation of inherited thrombotic microangiopathy-aHUS and TTP. Int J Lab Hematol 2020;42 Suppl 1:33-40. [PMID: 32543063 DOI: 10.1111/ijlh.13201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Dai YL, Tang X, Chen HB, Peng QY, Guo X, Gao J. Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene. Front Pediatr 2020;8:554. [PMID: 33014938 DOI: 10.3389/fped.2020.00554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Scully M. Congenital TTP: next stop, acuity and therapy. Blood 2021;137:3469-71. [PMID: 34165543 DOI: 10.1182/blood.2021011265] [Reference Citation Analysis]
13 Basu MK, Massicano F, Yu L, Halkidis K, Pillai V, Cao W, Zheng L, Zheng XL. Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura. Thromb Haemost 2021;121:506-17. [PMID: 33184803 DOI: 10.1055/s-0040-1719030] [Reference Citation Analysis]
14 Upreti H, Kasmani J, Dane K, Braunstein EM, Streiff MB, Shanbhag S, Moliterno AR, Sperati CJ, Gottesman RF, Brodsky RA, Kickler TS, Chaturvedi S. Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors. Blood 2019;134:1037-45. [PMID: 31431443 DOI: 10.1182/blood.2019001056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
15 Wyatt KD, Kohorst MA, Coon LM, Hurley RM, van Dorland HA, Arndt CAS. Hereditary Thrombotic Thrombocytopenic Purpura in a 9-Month-old: Diagnosing and Managing an Ultra-rare Disorder. J Pediatr Hematol Oncol 2021;43:e577-9. [PMID: 32496441 DOI: 10.1097/MPH.0000000000001830] [Reference Citation Analysis]
16 Katneni UK, Holcomb DD, Hernandez NE, Hamasaki-Katagiri N, Hunt RC, Bar H, Ibla JC, Kimchi-Sarfaty C. In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease. Thromb Res 2020;193:66-76. [PMID: 32531546 DOI: 10.1016/j.thromres.2020.05.042] [Reference Citation Analysis]
17 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2486-95. [PMID: 32914582 DOI: 10.1111/jth.15006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
18 Sun S, Urbanus RT, ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia. Cells 2021;10:3386. [DOI: 10.3390/cells10123386] [Reference Citation Analysis]
19 Patella F, Vendramin C, Charles O, Scully MA, Cutler DF. Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma. Res Pract Thromb Haemost 2021;5:e12626. [PMID: 34934893 DOI: 10.1002/rth2.12626] [Reference Citation Analysis]
20 Balduini C, Freson K, Greinacher A, Gresele P, Kühne T, Scully M, Bakchoul T, Coppo P, Dovc Drnovsek T, Godeau B, Gruel Y, Rao AK, Kremer Hovinga JA, Makris M, Matzdorff A, Mumford A, Pecci A, Raslova H, Rivera J, Roberts I, Scharf RE, Semple JW, Van Geet C. The EHA Research Roadmap: Platelet Disorders. Hemasphere 2021;5:e601. [PMID: 34476343 DOI: 10.1097/HS9.0000000000000601] [Reference Citation Analysis]
21 Fujimura Y, Lämmle B, Tanabe S, Sakai K, Kimura T, Kokame K, Miyata T, Takahashi Y, Taniguchi S, Matsumoto M. Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome. Blood Adv 2019;3:3191-5. [PMID: 31698449 DOI: 10.1182/bloodadvances.2019000601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Ferraresso F, Strilchuk AW, Juang LJ, Poole LG, Luyendyk JP, Kastrup CJ. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells. Mol Pharm 2022. [PMID: 35642083 DOI: 10.1021/acs.molpharmaceut.2c00033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pikovsky O, Arafat M, Ovadia H, Sharoni Y, Al-athamen K, Kanengisser-pines B, Keren-politansky A, Levi I, Erez O, Parvari R, Rabinovich A. Congenital thrombotic thrombocytopenic purpura in a large cohort of patients carrying a novel mutation in ADAMTS13 gene. Thrombosis Research 2020;185:167-70. [DOI: 10.1016/j.thromres.2019.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Karsenty CL, Kirk SE, Helber HL, Esquilin JM, Despotovic JM, Grimes AB. Molecular Diagnosis Is Vital to the Accurate Classification and Management of Thrombotic Thrombocytopenic Purpura in Children. Front Immunol 2022;13:836960. [DOI: 10.3389/fimmu.2022.836960] [Reference Citation Analysis]
25 Borogovac A, George JN. Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia. Blood Adv 2019;3:3973-6. [PMID: 31805189 DOI: 10.1182/bloodadvances.2019000959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
26 Rim JH, Choi YJ, Gee HY. Genomic Landscape and Mutational Spectrum of ADAMTS Family Genes in Mendelian Disorders Based on Gene Evidence Review for Variant Interpretation. Biomolecules 2020;10:E449. [PMID: 32183147 DOI: 10.3390/biom10030449] [Reference Citation Analysis]
27 Chen YY, Sun X, Huang W, He FF, Zhang C. Therapeutic apheresis in kidney diseases: an updated review. Ren Fail 2022;44:842-57. [PMID: 35723077 DOI: 10.1080/0886022X.2022.2073892] [Reference Citation Analysis]
28 Kremer Hovinga JA, Braschler TR, Buchkremer F, Farese S, Hengartner H, Lovey PY, Largiadèr CR, Mansouri Taleghani B, Tarasco E. Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland. Hamostaseologie 2020;40:S5-S14. [PMID: 33187004 DOI: 10.1055/a-1282-2264] [Reference Citation Analysis]
29 Zini G, De Cristofaro R. Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies. Turk J Haematol 2019;36:222-9. [PMID: 31337190 DOI: 10.4274/tjh.galenos.2019.2019.0165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Zhao T, Fan S, Sun L. The global carrier frequency and genetic prevalence of Upshaw-Schulman syndrome. BMC Genom Data 2021;22:50. [PMID: 34789164 DOI: 10.1186/s12863-021-01010-0] [Reference Citation Analysis]
31 Borogovac A, Tarasco E, Hovinga JAK, George JN. Hypertension in patients with hereditary thrombotic thrombocytopenic purpura. eJHaem 2020;1:342-3. [DOI: 10.1002/jha2.29] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Jain N, Oldenburg J, Ozelo MC, Sun SX, Tang L, Tzivelekis S. Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and thrombotic thrombocytopenic purpura presented at the 29th congress of the International Society on Thrombosis and Haemostasis (ISTH 2021, Jul 17-21; virtual congress). Expert Rev Hematol 2022;:1-18. [PMID: 35748691 DOI: 10.1080/17474086.2022.2074395] [Reference Citation Analysis]
33 Mingot Castellano ME, Pascual Izquierdo C, González A, Viejo Llorente A, Valcarcel Ferreiras D, Sebastián E, García Candel F, Sarmiento Palao H, Gómez Seguí I, de la Rubia J, Cid J, Martínez Nieto J, Hernández Mateo L, Goterris Viciedo R, Fidalgo T, Salinas R, Del Rio-Garma J; Grupo Español de Aféresis (GEA). Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura. Med Clin (Barc) 2021:S0025-7753(21)00332-8. [PMID: 34266669 DOI: 10.1016/j.medcli.2021.03.040] [Reference Citation Analysis]
34 Siddiqui A, Journeycake JM, Borogovac A, George JN. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer 2021;68:e28949. [PMID: 33660913 DOI: 10.1002/pbc.28949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chen X, Cheng X, Zhang S, Wu D. ADAMTS13: An Emerging Target in Stroke Therapy. Front Neurol 2019;10:772. [PMID: 31379722 DOI: 10.3389/fneur.2019.00772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Graça NAG, Joly BS, Voorberg J, Vanhoorelbeke K, Béranger N, Veyradier A, Coppo P. TTP: From empiricism for an enigmatic disease to targeted molecular therapies. Br J Haematol 2022. [PMID: 35146746 DOI: 10.1111/bjh.18040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Scully M. Hereditary thrombotic thrombocytopenic purpura. Haematologica 2019;104:1916-8. [PMID: 31575672 DOI: 10.3324/haematol.2019.225896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 George JN. Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond. Semin Thromb Hemost 2022. [PMID: 35793688 DOI: 10.1055/s-0042-1749589] [Reference Citation Analysis]
39 Tarasco E, Bütikofer L, Friedman KD, George JN, Hrachovinova I, Knöbl PN, Matsumoto M, von Krogh AS, Aebi-Huber I, Cermakova Z, Górska-Kosicka M, Jalowiec KA, Largiadèr CR, Prohászka Z, Sinkovits G, Windyga J, Lämmle B, Kremer Hovinga JA. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood 2021;137:3563-75. [PMID: 33649760 DOI: 10.1182/blood.2020009801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Chou SC, Lin DT, Lin CY, Huang YC, Hsieh HN, Shen MC. First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene. Int J Hematol 2021;113:760-4. [PMID: 33387295 DOI: 10.1007/s12185-020-03068-5] [Reference Citation Analysis]
41 Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update.J Neurol. 2021;268:3480-3492. [PMID: 33586004 DOI: 10.1007/s00415-021-10441-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Han X, Li C, Zhang S, Hou X, Chen Z, Zhang J, Zhang Y, Sun J, Wang Y. Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies. Thromb Res 2020;196:500-9. [PMID: 33091704 DOI: 10.1016/j.thromres.2020.10.005] [Reference Citation Analysis]
43 Zheng L, Zhang D, Cao W, Song WC, Zheng XL. Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy. Blood 2019;134:1095-105. [PMID: 31409673 DOI: 10.1182/blood.2019001040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
44 Sakai K, Fujimura Y, Miyata T, Isonishi A, Kokame K, Matsumoto M. Current prophylactic plasma infusion protocols do not adequately prevent long-term cumulative organ damage in the Japanese congenital thrombotic thrombocytopenic purpura cohort. Br J Haematol 2021;194:444-52. [PMID: 34046888 DOI: 10.1111/bjh.17560] [Reference Citation Analysis]
45 Mackie I, Mancini I, Muia J, Kremer Hovinga J, Nair S, Machin S, Baker R. International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. Int J Lab Hem 2020;42:685-96. [DOI: 10.1111/ijlh.13295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
46 Zheng XL. The standard of care for immune thrombotic thrombocytopenic purpura today. J Thromb Haemost 2021;19:1864-71. [PMID: 34060225 DOI: 10.1111/jth.15406] [Reference Citation Analysis]
47 Avery EJ, Kenney SP, Byers BD, McIntosh JJ, Hoover C, Jiang Y, Xia L, Yu Z, George JN. Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13 weeks' gestation. Am J Hematol 2020. [PMID: 32602158 DOI: 10.1002/ajh.25914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
48 Noda R, Kakinuma Y, Suzuki K, Ide S, Bae Y, Miyauchi A, Ishibashi Y. Pregnancy-onset thrombotic thrombocytopenic purpura with nephrotic syndrome: a case report. CEN Case Rep 2021. [PMID: 34623619 DOI: 10.1007/s13730-021-00654-2] [Reference Citation Analysis]
49 Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med 2021;10:536. [PMID: 33540569 DOI: 10.3390/jcm10030536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]